ArticleFrontiers in pharmacology2026

Platelet optimization in high-risk ALBI grade 3 patients undergoing invasive procedures: real-world evidence from lusutrombopag therapy.

Kongcai Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.